Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England | British Journal of Cancer
![PDF] Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0e2467d71afdaa8cd0f27aae283f3467c51fd5a9/3-Figure1-1.png "PDF] Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT) | Semantic Scholar")
PDF] Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT) | Semantic Scholar
Faecal immunochemical test for patients with 'high-risk' bowel symptoms: a large prospective cohort study and updated literature review | British Journal of Cancer
Role of the faecal immunochemical test in patients with risk-stratified suspected colorectal cancer symptoms: A systematic review and meta-analysis to inform the ACPGBI/BSG guidelines - The Lancet Regional Health – Europe
Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the “interval cancer” perspective | British Journal of Cancer
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer - Gastroenterology
Amazon.com: Second Generation FIT (Fecal Immunochemical Test) for Colorectal Cancer (2) : Health & Household
Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study - The Lancet Gastroenterology & Hepatology
For colorectal cancer, the only good screening test is one that is taken | Singlera Genomics
Age, male sex, smoking and metabolic syndrome as risk factors of advanced colorectal neoplasia for fecal immunochemical test negative patients - ScienceDirect
Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT‐based CRC screening program - Breekveldt - 2023 - International Journal of Cancer - Wiley Online Library
Manchester VA Medical Center - March is Colorectal Cancer Awareness Month. The U.S. Preventive Services Task Force advises that people at average risk for colorectal cancer start screening at age 50 and
Diagnostic performance of a faecal immunochemical test for patients with low-risk symptoms of colorectal cancer in primary care: an evaluation in the South West of England | British Journal of Cancer
Fecal Immunochemical Tests Performance Characterized for CRC - Clinical Chemistry - mobile.Labmedica.com
Colorectal Cancer Screening: Choosing the Right Test – Consult QD
Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme - Gavin RC Clark, Callum
Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme
Sensitivity of Fecal Immunochemical Test for Colorectal Cancer Detection Differs According to Stage and Location - Clinical Gastroenterology and Hepatology
Impact of the faecal immunochemical test on colorectal cancer survival | BMC Cancer | Full Text
FIT Test: At-Home Colon Cancer Screening Test Kit | Everlywell
Impact of the faecal immunochemical test on colorectal cancer survival | BMC Cancer | Full Text
Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme | Gut
